Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
08/09/2012 | US20120202219 Psa capture agents, compositions, methods and preparation thereof |
08/09/2012 | US20120201947 Advanced biorefinery process |
08/09/2012 | US20120201858 Multiple-arm peptide compounds, methods of manufacture and use in therapy |
08/09/2012 | US20120201855 Modified flagellin improved toll-like receptor 5 stimulating activity |
08/09/2012 | US20120201854 Modified flagellin improved toll-like receptor 5 stimulating activity |
08/09/2012 | US20120201853 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins |
08/09/2012 | US20120201848 Isolation of a virus related to canine parvovirus-2 from a raccoon |
08/09/2012 | US20120201844 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
08/09/2012 | US20120201841 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
08/09/2012 | US20120201840 EphA2 T-Cell Epitopes and Uses Therefor |
08/09/2012 | US20120201839 Allergy treatment using acid treated aqueous whey protein extract |
08/09/2012 | US20120201831 Human antibodies that bind human il-12 and methods for producing |
08/09/2012 | US20120201825 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection |
08/09/2012 | US20120201792 Methods and products for manipulating hematopoietic stem cells |
08/09/2012 | US20120201790 Promoters exhibiting endothelial cell specificity and methods of using same |
08/09/2012 | US20120201757 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide |
08/09/2012 | DE10113776B4 Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins An isolated streptavidinbindendes competitively elutable peptide, this complete fusion peptide, nucleic acid coding therefor, expression vector, to methods for producing a recombinant fusion protein, and methods for the detection and / or for the recovery of the fusion protein |
08/09/2012 | CA2826579A1 Peptide library |
08/09/2012 | CA2826248A1 Aerated food products |
08/09/2012 | CA2826200A1 Caspase-2 inhibitors |
08/09/2012 | CA2826142A1 Methods and materials for enhancing functional protein expression in bacteria |
08/09/2012 | CA2826114A1 Cardiotrophin related molecules for enhanced therapeutics |
08/09/2012 | CA2826060A1 Immunogenic bordetella bronchiseptica compositions |
08/09/2012 | CA2826041A1 Unnatural amino acids comprising a cyclooctynyl or trans-cyclooctenyl analog group and uses thereof |
08/08/2012 | EP2484769A2 Transgenic plants with enhanced agronomic traits |
08/08/2012 | EP2484692A1 Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same |
08/08/2012 | EP2484691A1 TNF superfamily collectin fusion proteins |
08/08/2012 | EP2484690A1 A method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family |
08/08/2012 | EP2484378A1 Hepatitis c virus vaccine composition |
08/08/2012 | EP2484365A1 Compositions and method for treatment of neovascular diseases |
08/08/2012 | EP2484364A1 Compositionas and methods for treatment of neovascular diseases |
08/08/2012 | EP2483403A1 Polypeptides having xylanase activity and polynucleotides encoding same |
08/08/2012 | EP2483396A2 Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7 |
08/08/2012 | EP2483395A1 A nuclear receptor and mutant thereof and the use of the same in the reprogramming of cells |
08/08/2012 | EP2483392A2 Umbilical cord lining stem cells and methods and material for isolating and culturing same |
08/08/2012 | EP2483389A2 Hyperblebbing shigella strains |
08/08/2012 | EP2483308A1 Drug fusions and conjugates with extended half life |
08/08/2012 | EP2483303A1 T-cell receptor capable of recognising an antigen from cytomegalovirus |
08/08/2012 | EP2483302A2 Parstatin peptides |
08/08/2012 | EP2483301A1 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
08/08/2012 | EP2483300A1 Synthetic myostatin peptide antagonists |
08/08/2012 | EP2483299A2 Splice variants |
08/08/2012 | EP2483298A1 Use of sirna targetting sipa1l1 for the reduction of adipogenesis |
08/08/2012 | EP2483297A1 Spider mite silk proteins |
08/08/2012 | EP2483296A1 Polypeptides derived from thermoascus crustaceus having cellulolytic enhancing activity and polynucleotides encoding same |
08/08/2012 | EP2483295A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
08/08/2012 | EP2483294A2 T-cell receptor |
08/08/2012 | EP2483293A1 Improved lov-d acyltransferase mediated acylation |
08/08/2012 | EP2483292A1 Variant lovd polypeptides and their uses |
08/08/2012 | EP2483291A1 New markers for the diagnosis of celiac disease |
08/08/2012 | EP2482843A1 Methods of improving vaccine immunogenicity |
08/08/2012 | EP2482836A1 Antibacterial polypeptides and use thereof |
08/08/2012 | EP2482833A1 Leptin agonist and methods of use |
08/08/2012 | EP2482825A1 Piscine reovirus diagnostic compositions |
08/08/2012 | EP2482824A1 Piscine reovirus immunogenic compositions |
08/08/2012 | EP2300497B1 A process of purifying coagulation factor viii |
08/08/2012 | EP2201376B1 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies |
08/08/2012 | EP2046815B1 Anti-inflammatory and antiallergic cyclic peptides |
08/08/2012 | EP2005171B1 Inflammation-inhibitory serum factors and uses thereof |
08/08/2012 | EP1984392B1 Novel cc-chemokine antagonists |
08/08/2012 | EP1959982B1 Methods and compositions for preventing and/or treating pancreatitis |
08/08/2012 | EP1933861B1 Method for treating or preventing multi-organ failure |
08/08/2012 | EP1913954B1 Use of the eda domain of fibronectin |
08/08/2012 | EP1913021B1 Polypeptides having an activity in the mtbe degradation path and uses thereof |
08/08/2012 | EP1585760B1 Btl-ii nucleic acids, proteins, and antibodies |
08/08/2012 | EP1569685B1 Complement receptor 2 targeted complement modulators |
08/08/2012 | EP1478750B1 Gene expression by positive feedback activation of a cell type-specific promoter |
08/08/2012 | EP1351981B1 A virus causing respiratory tract illness in susceptible mammals |
08/08/2012 | EP1263769B1 Dna molecules encoding a chloride channel in drosophila melanogaster |
08/08/2012 | EP0951551B2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
08/08/2012 | EP0837938B1 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
08/08/2012 | CN1496412B Method for estimating danger of diabetes typ B developed in the human species of Chinese bloodline and composition |
08/08/2012 | CN102628072A Preparation method of insulin |
08/08/2012 | CN102628062A Expression method of animal alpha interferon and gamma interferon |
08/08/2012 | CN102628058A Preparation of recombinant human nerve growth factor ( rhNGF ) protein and renaturation solution |
08/08/2012 | CN102628052A Rice disease resistance related gene, encoding protein thereof and preparation method for strain for improving rice broad spectrum disease resistance |
08/08/2012 | CN102628049A Chilo suppressalis ryanodine receptor gene CsRyR, encoded protein thereof and application of chilo suppressalis ryanodine receptor gene CsRyR |
08/08/2012 | CN102628048A Preparation and application of conotoxin Lt7b of Conus littertus Linnaeus of South China sea |
08/08/2012 | CN102627696A Preparation method of phencyclidine artificial antigen |
08/08/2012 | CN102627695A Primary biliary cirrhosis specific autoantigen and application thereof |
08/08/2012 | CN102627694A Method for extracting wheat bran protein |
08/08/2012 | CN102627693A High-affinity penicillin binding protein and application thereof |
08/08/2012 | CN102627692A A pair of transcription activator-like effector nucleases and coding engines as well as application thereof |
08/08/2012 | CN102627691A Pair of transcriptional activation subsample effect factor nucleases and coding gene and application thereof |
08/08/2012 | CN102627690A Pair of transcription activator-like effector nucleases (TALENs) and coding genes and application thereof |
08/08/2012 | CN102627628A Chlorantraniliprole antigen, its preparation method and application |
08/08/2012 | CN102080078B Cotton NAC transcription factor gene and application thereof |
08/08/2012 | CN102021185B Function and usage of magnaporthe oryzae MoCHS1 gene and coded protein thereof |
08/08/2012 | CN101948845B Optimization gene for coding chicken interferon alpha and application thereof in preparing chicken interferon alpha |
08/08/2012 | CN101935346B Mutated human-source fibroblast growth factor and application in treating endocrine diseases |
08/08/2012 | CN101914548B Bovine embryo sex development related gene, encoding protein and preparation method thereof |
08/08/2012 | CN101792489B Preparation and application of human galectin-9 deletant for enhancement of immune response |
08/08/2012 | CN101781366B Novel antibacterial peptide and preparation method and application thereof |
08/08/2012 | CN101748069B Recombinant blue-green algae |
08/08/2012 | CN101724010B Preparation method and application of tumor tissue complete antigen |
08/08/2012 | CN101628938B Extraction technology of macromolecular collagen protein |
08/08/2012 | CN101580534B CpTI enzyme-linked immunoassay reagent kit as well as preparation method and application thereof |
08/08/2012 | CN101516902B Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
08/08/2012 | CN101348519B Preparation technique and use of ricefield eel antibacterial peptide |
08/08/2012 | CN101328484B Delta-endotoxin genes and methods for their use |